Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy: the more the better? Overview

N Saijo1

  • 1Pharmacology Division, National Cancer Center Research Institute, Tokyo, Japan.

Cancer Chemotherapy and Pharmacology
|January 1, 1997
PubMed
Summary

High-dose chemotherapy offers limited proven benefits over standard treatments. Future trials should focus on drug-sensitive tumors and confirm efficacy via randomized studies for improved cure rates or survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.

British journal of cancer·2011
Same author

Cross-resistance to antineoplastic agents in a human small-cell lung-cancer subline resistant to okadaic Acid.

Oncology reports·2011
Same author

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

Oncogene·2011
Same author

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606).

British journal of cancer·2010

Area of Science:

  • Oncology
  • Clinical Pharmacology

Background:

  • Numerous clinical trials have investigated high-dose chemotherapy (HDC) without consistently demonstrating superior outcomes.
  • The efficacy of dose-intensive chemotherapy requires further validation against established therapeutic approaches.

Purpose of the Study:

  • To evaluate the effectiveness of high-dose chemotherapy strategies.
  • To define the appropriate application of dose-intensive chemotherapy in clinical practice.

Main Methods:

  • Review of existing clinical trials on high-dose chemotherapy.
  • Analysis of primary endpoints such as cure rates and survival.
  • Recommendation for future randomized clinical trials.

Main Results:

  • Few high-dose chemotherapy trials have shown statistically significant improvements over standard therapies.
  • The benefits of dose-intensive chemotherapy are not universally established.

Conclusions:

  • High-dose chemotherapy should be reserved for drug-sensitive tumors.
  • Randomized clinical trials are essential to confirm the superiority of dose-intensive chemotherapy for increasing cure rates or prolonging survival.

Related Experiment Videos